2025-10-30 - Analysis Report
Okay, here's an analysis of Sempra (SRE) based on the provided data, presented in a structured and informative way.

**Report on Sempra (SRE)**

**1. Performance Relative to S&P 500 (VOO)**

*   **Ticker:** SRE
*   **Company:** Sempra (an energy infrastructure company)

**Key Numbers:**

*   SRE Cumulative Return: 20.02%
*   VOO Cumulative Return: 104.04%
*   Deviation (SRE - VOO):
    *   Current: -79.5
    *   Max: 13.9
    *   Min: -92.4
    *   Relative Deviation: 12.1

**Analysis:**

Sempra has significantly underperformed the S&P 500 (VOO) over the period examined. The current deviation is -79.5%, and the relative deviation of 12.1 suggests SRE is near the lower end of its historical performance range relative to VOO. This substantial underperformance warrants further investigation.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
| ---------- | ------ | ------ | ------- | ------ | ------ |
| 2015-2017  | 8.0%   | 70.6%  | -20.0%  | 0.0    | 34.9   |
| 2016-2018  | 11.0%  | 71.1%  | -4.0%   | 0.1    | 35.3   |
| 2017-2019  | 35.0%  | 71.1%  | 13.0%   | 0.3    | 49.4   |
| 2018-2020  | -4.0%  | 80.1%  | -28.0%  | 0.2    | 41.6   |
| 2019-2021  | -2.0%  | 80.1%  | -49.0%  | 0.4    | 43.1   |
| 2020-2022  | -15.0% | 81.1%  | -14.0%  | 0.4    | 50.4   |
| 2021-2023  | 22.0%  | 81.1%  | 20.0%   | 0.5    | 48.8   |
| 2022-2024  | 11.0%  | 81.1%  | -10.0%  | 0.6    | 57.2   |
| 2023-2025  | -9.0%  | 74.5%  | -78.0%  | -0.2   | 60.5   |

**Analysis:**

*   **CAGR:** Sempra's CAGR has fluctuated significantly over the different periods.
*   **MDD:** The Maximum Drawdown (MDD) is high, indicating significant potential losses.
*   **Alpha:** Alpha values are mostly negative, particularly in recent years. This further confirms underperformance relative to the benchmark. A negative alpha suggests the investment has performed worse than expected for the risk taken.
*   **Beta:** Beta values are generally low, sometimes negative, indicating low volatility compared to the market. The negative beta in the 2023-2025 period suggests that Sempra's returns moved inversely with the market during that timeframe.
*   **Cap(B):** Market capitalization has generally increased over time.

**2. Recent Stock Price Movements**

*   Current Price: 92.7083
*   Last Market Data: {'price': 92.73, 'previousClose': 92.55, 'change': 0.19}
*   5-Day Moving Average: 92.5057
*   20-Day Moving Average: 91.7474
*   60-Day Moving Average: 85.8605

**Analysis:**

The stock is trading slightly above its 5-day and 20-day moving averages, suggesting a possible short-term upward trend. The price is significantly above the 60-day moving average, indicating a stronger longer-term upward trend. The recent price change of 0.19 is relatively small and doesn't suggest any immediate major price swings.

**3. Market Risk Indicators and Hybrid Signal**

*   MRI: 0.9 (High Investment Recommended)
*   RSI: 46.97 (Neutral)
*   PPO: -0.25 (Slightly Oversold)
*   Recent (20-day) Relative Deviation Change: -1.4 (Short-term decline)
*   Expected Return (%): -228.0
*   Hybrid Signal: cash_0%_Buy 100% of cash (23 shares - Very Safe - MRI:0.90) Dividend_0.65 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)

**Analysis:**

*   **MRI:** A high MRI suggests the stock is relatively safe compared to the overall market risk.
*   **RSI:** The RSI is near 50, indicating a neutral market momentum.
*   **PPO:** The PPO is slightly negative, suggesting the stock may be slightly oversold in the short term.
*   **Relative Deviation Change:** The recent decline in relative deviation confirms short-term underperformance compared to the S&P 500.
*   **Expected Return:** The very negative expected return (-228.0%) indicates that, based on current data, long-term investment in Sempra is predicted to significantly underperform the S&P 500.  This is a crucial point.
*   **Hybrid Signal:** The Hybrid Signal recommends buying Sempra based on current indicators.

**4. Recent News & Significant Events**

*   **Earnings Growth Expectations:** Zacks reports Wall Street expects earnings growth.
*   **Valuation:** Simply Wall St. revisits Sempra's valuation after recent gains.
*   **Analyst Ratings:**
    *   Jefferies adjusts price target DOWN to $89 (Hold rating).
    *   BMO raises price target UP to $99 (Outperform rating).
    *   BTIG initiates coverage with a Buy rating.

**Analysis:**

The news is mixed. While there's optimism regarding earnings growth, analyst opinions are divided. The price target adjustments (one up, one down) and initiations suggest uncertainty regarding Sempra's future valuation.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.94)
*   **Opinions:** 15 analysts
*   **Target Price:**
    *   Average: $95.67
    *   High: $115.00
    *   Low: $80.00

**Analysis:**

The analyst consensus is generally positive ("Buy"), with an average price target of $95.67. However, there's a wide range in price targets, suggesting differing views on the stock's potential.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
| ---------- | ---- | ---------- |
| 2025-08-07 | 0.71 | 2.70 B$    |
| 2025-05-08 | 1.39 | 3.68 B$    |
| 2024-11-06 | 1.01 | 2.57 B$    |
| 2024-08-06 | 1.13 | 2.48 B$    |
| 2025-08-07 | 1.13 | 2.48 B$    |

**Analysis:**

Sempra's EPS and revenue have fluctuated over the past few quarters. While the most recent EPS (0.71) is lower than previous quarters, revenue in the most recent quarter is improved (1.13 -> 2.48). It's important to look at the trends over a longer period to determine the overall health of Sempra's earnings performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
| ---------- | -------- | ------------- |
| 2025-06-30 | $3.00B   | 46.73%        |
| 2025-03-31 | $3.80B   | 47.21%        |
| 2024-12-31 | $3.76B   | 49.23%        |
| 2024-09-30 | $2.78B   | 44.49%        |
| 2024-06-30 | $3.01B   | 44.20%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE    |
| ---------- | --------- | ------ |
| 2025-06-30 | $31.72B  | 1.49%  |
| 2025-03-31 | $31.66B  | 2.90%  |
| 2024-12-31 | $31.24B  | 2.16%  |
| 2024-09-30 | $29.72B  | 2.18%  |
| 2024-06-30 | $29.50B  | 2.46%  |

**Analysis:**

*   **Revenue:** Revenue has fluctuated, with the highest revenue in Q1 2025.
*   **Profit Margin:** Profit margins have remained relatively stable.
*   **Equity:** Equity has steadily increased.
*   **ROE:** Return on Equity (ROE) has fluctuated, with the highest ROE in Q1 2025, but has decreased significantly in the most recent quarter. A lower ROE suggests that the company is not generating as much profit from its equity as it has in the past.

**7. Overall Summary**

Based on the provided data, here's a concise summary:

*   **Underperformance:** Sempra has significantly underperformed the S&P 500, with a large current deviation and negative alpha values in recent periods.
*   **Mixed Signals:** While recent price action shows a short-term upward trend, the negative expected return is a significant red flag. Analyst opinions are mixed, with varying price targets.
*   **Fluctuating Financials:** Revenue, EPS, and ROE have fluctuated recently. While equity has increased, recent earnings and ROE decline may be a cause for concern.
*   **Earnings Growth Potential:** Upcoming earnings announcement is expected, which could be a catalyst for price movement.

**Conclusion:**

The data presents a complex picture. While Sempra has a "Buy" analyst consensus and a high MRI suggesting safety, the significant underperformance relative to the S&P 500 and the very negative expected return warrant caution. The mixed news, fluctuating financials, and divided analyst opinions further contribute to the uncertainty. Investors should carefully weigh these factors before making any investment decisions. It's highly recommended to conduct further research and due diligence before investing in SRE.
